---
layout: default
nav_exclude: true
title: Rasburicase
---

# Rasburicase

**Generic Name:** Rasburicase

**Usage:**

Rasburicase is used to prevent or treat hyperuricemia (high levels of uric acid in the blood).  This is particularly important in patients undergoing cancer chemotherapy or other treatments that cause tumor lysis syndrome (TLS). TLS is a potentially life-threatening condition where the rapid breakdown of cancer cells releases large amounts of uric acid into the bloodstream, leading to kidney damage and other complications.  Rasburicase is also sometimes used in patients with severe gout who haven't responded to other treatments.

**Side Effects:**

Rasburicase can cause a range of side effects, some mild and others serious.  These include:

* **Common side effects:** Nausea, vomiting, diarrhea, abdominal pain, headache, rash, flushing.
* **Serious side effects:**  **Methaemoglobinaemia** (a decrease in the blood's ability to carry oxygen, potentially leading to shortness of breath, bluish discoloration of the skin, and even death), **hemolytic anemia** (destruction of red blood cells), allergic reactions (ranging from mild rash to anaphylaxis), and kidney problems.  **Acute respiratory distress syndrome (ARDS)** has also been reported.

It's crucial to note that the risk of serious side effects is increased in patients with pre-existing kidney or liver disease, glucose-6-phosphate dehydrogenase (G6PD) deficiency (a genetic condition), or those receiving certain other medications.

**How it Works:**

Rasburicase is a recombinant urate oxidase enzyme.  Urate oxidase is an enzyme naturally found in many mammals (but not humans) that catalyzes the breakdown of uric acid into allantoin, a more soluble and easily excreted substance. By administering rasburicase, the body can more efficiently eliminate uric acid, thus preventing or treating hyperuricemia.

**FAQs:**

* **Q: Is rasburicase safe?** A: Rasburicase can be effective in preventing or treating hyperuricemia, but it carries a risk of serious side effects, especially methemoglobinemia and hemolytic anemia.  The benefits and risks must be carefully weighed by a healthcare professional.
* **Q: Who should not take rasburicase?** A: Patients with known G6PD deficiency, severe kidney or liver disease, or a history of severe allergic reactions to rasburicase should generally not take this medication.  Pregnant or breastfeeding women should also discuss the risks and benefits with their doctor.
* **Q: What are the monitoring requirements for rasburicase?** A:  Close monitoring of blood counts (to detect hemolytic anemia), methemoglobin levels, and kidney function is crucial during and after rasburicase treatment.
* **Q: Are there alternatives to rasburicase?** A: Yes, other medications such as allopurinol or febuxostat can be used to treat or prevent hyperuricemia, but they work differently and may not be appropriate in all situations, especially the acute setting of TLS.  Hydration and alkalinization of urine are also important supportive measures.
* **Q: How is rasburicase administered?** A: It is typically administered intravenously (by injection into a vein).


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional before starting or stopping any medication.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.